Clementia Pharmaceuticals-BLOCK

Home » Clementia Pharmaceuticals-BLOCK

Secondary

Clementia Pharmaceuticals-BLOCK

Clementia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops disease-modifying treatments for patients suffering from debilitating bone and other diseases.

Symbol

CMTA

Last Closing Price
$18.21

Shares
780,000

Effective Date
January 30, 2018

Underwriters
Morgan Stanley

To view the prospectus for Clementia Pharmaceuticals-BLOCK, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253